Zobrazeno 1 - 10
of 20
pro vyhledávání: '"A. Rothhoff"'
Publikováno v:
Case Reports in Transplantation, Vol 2015 (2015)
About forty years ago the complement-dependent crossmatch assay (CDC-CM) was developed as standard procedure in order to select recipients without donor-specific antibodies directed against human leukocyte antigens of their given donors since the neg
Externí odkaz:
https://doaj.org/article/d294f57f5e2a47feb8db9829defa5c64
Publikováno v:
Transfusionsmedizin - Immunhämatologie, Hämotherapie, Immungenetik, Zelltherapie. 6:169-173
Donorspezifische Anti-HLA-Antikorper stellen die haufigste Ursache fur hyperakute bzw. akute Abstosungsepisoden nach Transplantationen solider Organe dar. Zum Ausschluss dieser Antikorper wurde bereits vor mehr als 40 Jahren der komplementabhangige L
Publikováno v:
Case Reports in Transplantation, Vol 2015 (2015)
Case Reports in Transplantation
Case Reports in Transplantation
About forty years ago the complement-dependent crossmatch assay (CDC-CM) was developed as standard procedure in order to select recipients without donor-specific antibodies directed against human leukocyte antigens of their given donors since the neg
Publikováno v:
Case Reports in Transplantation.
About forty years ago the complement-dependent crossmatch assay (CDC-CM) was developed as standard procedure in order to select recipients without donor-specific antibodies directed against human leukocyte antigens of their given donors since the neg
Publikováno v:
Journal of Clinical & Cellular Immunology.
Systemic lupus erythematosus (SLE) is known to proceed to clinically relevant nephritis in more than 50% of patients and, in about 20% of these patients, to terminal renal failure. Thus, renal replacement therapy including kidney allografting is requ
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 22(10)
Previous studies have suggested that the pre-transplant levels of the soluble CD30 molecule (sCD30) represent a non-invasive tool which can be used as a biomarker for the prediction of kidney allograft rejections.In order to evaluate the feasibility
Publikováno v:
Transfusionsmedizin; November 2016, Vol. 6 Issue: 4 p169-173, 5p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Scopus-Elsevier
DIGITUM. Depósito Digital Institucional de la Universidad de Murcia
instname
DIGITUM. Depósito Digital Institucional de la Universidad de Murcia
instname
The CD30 molecule, a 120 kDa cell surface glycoprotein, is a member of the tumor necrosis factor receptor (TNF-R) superfamily and was originally identified on the surface of Reed-Sternberg cells and anaplastic large cell lymphomas in Hodgkin’s dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2c5ea904592dc694c6caf9893a70f3a2
http://www.scopus.com/inward/record.url?eid=2-s2.0-34748820022&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-34748820022&partnerID=MN8TOARS